¥2,040.00 ($12.93)

+3.00 (+0.15%)

Weekly Expected Move ±1.7%

¥1968 ¥2003 ¥2037 ¥2071 ¥2106

JPX · Healthcare · Medical - Distribution · Tech Score Buy · Power 64 · ¥10.9B mcap · 1M float · 0.690% daily turnover

Analysis Technicals Weather Peers

Revenue

$21.5B +21.4% ▲

5Y CAGR: +24.8%

Gross Profit

$9.6B +14.9% ▲

5Y CAGR: +11.7%

Operating Income

$294M +153.1% ▲

5Y CAGR: +11.5%

Net Income

$88M +104.2% ▲

5Y CAGR: -1.9%

EPS (Diluted)

$17.21 +104.0% ▲

5Y CAGR: -3.9%

EBITDA

$915M +174.8% ▲

5Y CAGR: +30.8%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$8.5B	$11.9B	$16.8B	$17.7B	$21.5B
YoY Growth	+19.5%	+39.8%	+41.8%	+5.2%	+21.4%
Cost of Revenue	$1.9B	$6.5B	$9.7B	$9.4B	$11.9B
Gross Profit	$6.6B	$5.4B	$7.1B	$8.3B	$9.6B
Gross Margin	78.0%	45.5%	42.2%	47.0%	44.5%
R&D Expenses	$130M	$8M	$107M	$74M	$0
SG&A Expenses	$5.8B	$4.6B	$8.6B	$8.5B	$0
Operating Expenses	$6.0B	$4.7B	$8.9B	$8.9B	$9.3B
Operating Income	$672M	$731M	-$1.8B	-$553M	$294M
Operating Margin	7.9%	6.2%	-10.8%	-3.1%	1.4%
Interest Expense	$762K	$1M	$11M	$27M	$59M
Income Before Tax	$679M	$700M	-$1.8B	-$1.7B	$248M
Tax Expense	$254M	$300M	$21M	$370M	$117M
Net Income	$425M	$401M	-$1.9B	-$2.1B	$88M
Net Margin	5.0%	3.4%	-11.3%	-11.8%	0.4%
EPS (Diluted)	$92.64	$86.68	$-410.60	$-426.06	$17.21
EBITDA	$706M	$761M	-$1.5B	-$1.2B	$915M
Shares Outstanding	5M	5M	5M	5M	5M

Line Item	FY2023 Q2	FY2023 Q3	FY2023 Q4	FY2024 Q1	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1
Revenue	$3.8B	$4.4B	$5.3B	$5.4B	$5.4B	$5.5B	$5.2B	$5.0B
Cost of Revenue	$2.0B	$2.5B	$2.9B	$2.9B	$3.0B	$3.4B	$3.0B	$3.0B
Gross Profit	$1.8B	$1.9B	$2.4B	$2.5B	$2.4B	$2.2B	$2.2B	$2.0B
Gross Margin	48.2%	43.1%	45.1%	46.7%	45.2%	39.1%	42.3%	39.8%
R&D Expenses	$7M	$0	$74M	$0	$0	$0	$80M	$0
SG&A Expenses	$2.1B	$2.0B	$2.1B	$2.5B	$2.3B	$2.1B	$1.5B	$2.0B
Operating Expenses	$2.1B	$2.2B	$2.6B	$2.5B	$2.3B	$2.1B	$2.1B	$2.0B
Operating Income	-$258M	-$110M	-$222M	$18M	$113M	$70M	$92M	-$17M
Operating Margin	-6.8%	-2.5%	-4.2%	0.3%	2.1%	1.3%	1.8%	-0.3%
Interest Expense	$4M	$6M	$11M	$11M	$13M	$15M	$20M	$18M
Income Before Tax	-$263M	-$109M	-$1.3B	$14M	$102M	$75M	$56M	-$5M
Tax Expense	-$6M	$16M	$302M	$18M	$46M	-$20M	$72M	$22M
Net Income	-$255M	-$128M	-$1.7B	-$19M	$26M	$113M	-$34M	-$36M
Net Margin	-6.7%	-2.9%	-31.3%	-0.4%	0.5%	2.1%	-0.7%	-0.7%
EPS (Diluted)	$-51.92	$-25.99	$-289.63	$-3.83	$5.10	$22.53	$-6.43	$-6.90
EBITDA	-$259M	-$221M	-$960M	$120M	$212M	$346M	$236M	$155M
Shares Outstanding	5M	5M	5M	5M	5M	5M	5M	5M

2934.T JPX